The advancement and evolution of Technologies has resulted businesses to adapt and incorporate these technologies into their business processes. With the evolution of Robotics and Automation, many Manufacturing firms are undergoing tremendous amount of Digital Transformation which has led to change in the ways of doing business. To increase Efficiency and Effectives, an emerging concept of Plant Digitization is getting into the spotlight. The power of Data Collection to Data Visualization has helped corporates to make necessary decisions right from the business strategy to on floor embedding of sensors for better understanding of machine behaviors.

The big data and analytics market is expected to grow at over `10% to be a USD 229 billion market in 2025. Numerous growth engines are expected to fuel its adoption – the increasing use of Internet of Things (IoT) devices among organizations, increasing availability of data across the organizations to gain deeper insights to remain competitive, and increasing digital transformation initiatives among enterprises.

The adoption of advanced big data technologies with minimal infrastructure, cost-effectiveness offered by the big data solutions, and immediate need for actionable intelligence for enhanced decision-making will provide attractive, high growth opportunities in the big data and analytics market. Participants such as CIOs, CTOs, CMOs, analytics solution and service providers, and system integrators can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the big data  and analytics space, as seen through the lens of eminent CXOs in this space.

The industrial and services robot market are expected to grow at over `18% to be a $176 billion market in 2025. Numerous engines are expected to fuel its growth – A.I in Robotics, Cloud Robotics, Connected Autonomous Systems, Enterprise Robotic Automation, COBOTS, Biorobotics, Exoskeletons, Biped and Humanoids, Unmanned Aerial Systems, Advanced Vision Systems, Implantable sensors for Robotics as well as others.

A host of attractive, high growth opportunities such as Smart Factory, Precision Agriculture, Last Mile Delivery, Warehouse Automation, Cooperative & Network Robotics, Entertainment Robotics, Robotics in industrial monitoring, IOT/Industry 4.0 etc could be pursued. Participants such as system integrators, OEMs, Software and Programming vendors, End of Arm tool manufacturers, Drives and control system providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Robotics ecosystem, as seen through the lens of eminent CXOs in this space.

Market intelligence provides a comprehensive perspective of any industry’s depth, both economically and philosophically. Organizations cannot afford to scrimp on acquiring market knowledge in today’s fast-paced economy. Missing up on these advantages can be the difference between success and failure. Explore new business strategies to gain a competitive edge at 2nd Edition MarketsandMarkets Competitive and Market Intelligence Virtual Summit- US, scheduled to be held on 21st - 22nd September 2021. Join us for a two-day virtual conference to discuss challenges, opportunities to create effective and efficient business practices.

The sequencing industry is experiencing significant growth due to the rising incidence of chronic diseases like Covid 19 and its impact, prevalence of diseases, increasing focus on the development of regenerative medicines, and improving healthcare infrastructure

The global DNA sequencing market size was valued at USD 4.7 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2020 to 2027.

However, with complexities in maintaining the quality of input is lower, adaptation of technologies to clinic specimens is a difficult task, such factors keep adding to the hinderance in their development.

The paints & coatings market is expected to be a $179 billion market in 2025. The growth of end-use industries such as architectural, general industrial, protective, and automotive & transportation is driving the paints & coatings market growth.
A host of attractive, high growth opportunities such as Smart Coatings, NanoCoatings, Anti-Icing Coating, anti-microbial coatings, polyurea coatings, UV coatings, etc could be pursued. Participants such as Paints & Coatings Manufacturer, Resin, Solvent, and Additives manufacturers can benefit from this unprecedented growth over the next 5 years.

The adhesives market is expected to be a $70 billion market in 2025. The major drivers for the market are increased demand for adhesives in the medical industry, increasing demand for adhesives & sealants from the building & construction industry, and growth in the appliances industry.

A host of attractive, high growth opportunities such as EV Adhesives, Electronic Adhesives, medical adhesives, etc could be pursued. Participants such as Adhesives Manufacturer, Resin, Curing Agent, Additives & fillers manufacturers can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Paints & Coatings  ecosystem, as seen through the lens of eminent CXOs in this space.

The pandemic has disrupted healthcare systems frameworks around the world, with hospitals be-ing overwhelmed due to the increasing influx of patients. The spread of COVID-19 has prodded a surge in demand for cleaning and disinfection products due to the growing awareness about hy-giene, health, and safety.

The utilization of reprocessed equipment to disinfect or sterilize medical devices is higher than normal now since improper decontamination of surgical instruments, endoscopic devices, respira-tory care devices, and reusable hemodialysis machines can increase the chances of healthcare as-sociated infections. Patient-to-patient pathogen transmission via medical devices can be entirely prevented by properly sterilising medical devices

The pandemic has disrupted healthcare systems frameworks around the world, with hospitals being overwhelmed due to the increasing influx of patients. The spread of COVID-19 has prodded a surge in demand for cleaning and disinfection products due to the growing awareness about hygiene, health, and safety. The increasing healthcare expenditure in North America being the major factor driving the demand and uptake of antiseptics and disinfectants in the region.

The utilization of reprocessed equipment to disinfect or sterilize medical devices is higher than normal now since improper decontamination of surgical instruments, endoscopic devices, respiratory care devices, and reusable hemodialysis machines can increase the chances of healthcare associated infections. Patient-to-patient pathogen transmission via medical devices can be entirely prevented by properly sterilizing medical devices.

Market intelligence provides a comprehensive perspective of any industry’s depth, both economically and philosophically. Organizations cannot afford to scrimp on acquiring market knowledge in today’s fast-paced economy. Missing up on these advantages can be the difference between success and failure.

The Artificial Intelligence (AI) market is expected to grow at over `36% to be a $190 Bn market in 2025. Numerous engines are expected to fuel its growth – increase in amount of big data, increased adoption of cloud-based applications and services, increase in demand for virtual assistants, emergence of new use cases as well as others.

From computer vision systems and predictive analytics improving manufacturing operations to self-learning algorithms that help us make better decisions, the AI/ML algorithms will continue to evolve and provide a host of attractive, high growth opportunities. Participants such as CIOs, CTOs, CMOs, AI hardware providers, AI solution and service providers, automation technology providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the AI space, as seen through the lens of eminent CXOs in this space.

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

More than just a term, Mergers and Acquisition process encompasses far more complex procedures and after transaction challenges. Numerous challenges like cultural fit, integration, infrastructure, etc. has led organizations to adopt a more clear and strategic approach to these MnA transactions. These challenges not only force the organization to bring changes to their business process but also mission and vision of the stakeholders.

MarketsandMarkets is proud to announce the 5th Edition Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference to be held on October 19-22, 2021. The expanding utilization of Real World Evidence to speed up data driven choices is further developing the clinical trial experience, but healthcare in general. 

While there is extraordinary promise in utilizing Real World Data and Real World Evidence, there are some significant challenges that should be survived: potential bias of information and data sources, inadequate data sets and absence of harmonization of data between RWE data sources, access to such data, and lack of standards in evaluating the worth of Real World Evidence data. Further developing RWE is key for pharma organizations in drug development. There was big data available pre covid and now with the access data due to covid, technology enablers like AI and ML are important for big data analysis and evidence generation. Every stakeholder has faced a some impact and had to adjust. 

The end product sales in bioproduction market are expected to grow at over `15% to be a $305 Bn market in 2025. Numerous engines are expected to fuel its growth – Cell Therapy, Gene Therapy, Monoclonal Antibodies, Vaccines, biosimilars and biobetters, plasma therapy as well as others.

A host of attractive, high growth opportunities such as single use systems, Lab Scale and CGMP manufacturing and R&D, Crispr and other Gene editing tools and technologies, Novel downstream bioprocessing methods etc could be pursued. Participants such as CROs, CMOs, Bioprocess solutions manufacturers, Biobanks, automation technology providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Bioproduction ecosystem, as seen through the lens of eminent CXOs in this space

Our 5th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress to be held on 26 - 29 October 2021 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference.

MarketsandMarkets is proud to announce the 2nd Annual MarketsandMarkets Biosimilars Virtual Conference to be held on 11th- 12th November.

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.

Technological innovation influences mission-critical applications in business processes and the manufacturing and technology companies that take the risk and are early adopters of new technology will be rewarded for their progressive decision-making. Since, digitization helps to ensure product quality and safety, as well as faster service delivery, it ensures to go a long way with customers. This has made the IoT adaptation the need of hour!
 

MarketsandMarkets is proud to announce the 3rd Annual MarketsandMarkets World Pharma Supply Chain and Cold Chain Logistics Conference on 21st -22nd June 2022 to be held in Boston, USA.

The event will witness an overwhelming participation of leading supply chain and logistics decision makers.